Panel Discussion: Building Strategic Vendor Partnerships to Support Seamless Progression from Clinical Development to Commercial Manufacturing
- Selecting vendors with proven capability to scale support from early clinical phases through commercial launch and beyond
- Conducting comprehensive due diligence to evaluate vendor reliability, regulatory compliance, and long-term partnership potential amid evolving market complexities
- Collaborating with automation vendors early in product development to influence their pipelines and ensure tools meet specific biotechnology requirements